Keyhole Therapeutics
PrivateCompany Overview
Keyhole Therapeutics is a biotechnology company that develops first-in-class immunotherapies for cancer and autoimmune diseases by targeting exosome-mediated immune suppression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologydrug discoveryimmunotherapyexosomesmall molecule inhibitorcancer researchautoimmune diseasepreclinical drugimmune checkpoint inhibitorbiotech startupimmuno-oncologydrug pipelinetherapeutic developmentev inhibitorbiotech R&D
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Keyhole Therapeutics Comparables
Compare Keyhole Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EV Therapeutics | 80% | |
| Aluda Pharmaceuticals | 74% | |
| Relay Therapeutics | 65% | |
Keyhole Therapeutics Funding Rounds
Historical fundraising activity
Keyhole Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Keyhole Therapeutics's valuation, stock price, and market status.
See something wrong or outdated?